血清刺激性甲状腺球蛋白水平在分化型甲状腺癌诊断及预后预测中的价值

Value of serum stimulant thyroglobulin level in the diagnosis and predicting prognosis of differentiated thyroid carcinoma

  • 摘要:
      目的  探讨血清刺激性甲状腺球蛋白(ps-Tg)水平与分化型甲状腺癌(DTC)患者临床病理特征的关系及对术后复发转移的预测价值。
      方法  选取361例DTC患者作为研究对象,根据其随访期是否复发转移分为复发转移组(n=38)和非复发转移组(n=323)。分析术后血清ps-Tg水平与DTC患者临床病理特征的关系,并分析DTC复发转移情况与术后血清ps-Tg水平的关系。采用Cox回归模型分析DTC患者术后复发转移的危险因素,采用受试者工作特征(ROC)曲线分析术后血清ps-Tg水平对DTC患者术后复发转移的预测价值。
      结果  不同性别、年龄、肿物内部微钙化情况患者的血清ps-Tg水平比较,差异无统计学意义(P>0.05);不同肿瘤位置、肿瘤最大直径、病灶数量、肿物与甲状腺被膜的关系、肿物内部及周边血流患者的血清ps-Tg水平比较,差异有统计学意义(P < 0.05)。复发转移组患者术后血清ps-Tg水平高于非复发转移组患者,差异有统计学意义(P < 0.05)。Cox回归分析发现,术后血清ps-Tg水平较高、肿瘤最大直径≥1 cm、多病灶、肿物与甲状腺被膜边界欠清晰或不清晰、肿物内部及周边血流丰富或较丰富是DTC患者术后复发转移的独立危险因素(P < 0.05)。ROC分析显示,DTC患者术后血清ps-Tg水平预测远期复发转移的最佳截断值为13.60 ng/mL,曲线下面积(AUC)为0.743,95% CI为0.555~0.995,对应的灵敏度、特异度分别为0.711、0.795。
      结论  术后血清ps-Tg水平异常升高多提示DTC患者临床病理类型不佳,且对患者远期复发转移具有一定预测价值。

     

    Abstract:
      Objective  To investigate the relationship between serum stimulated thyroglobulin(ps-Tg) level and clinicopathological characteristics of patients with differentiated thyroid carcinoma (DTC), and its predictive value for metastasis and reoccurrence.
      Methods  A total of 361 DTC patients were selected, and divided into recurrent and metastatic group(n=38) and non-recurrent and metastatic group(n=323) according to the recurrence and metastasis status during the follow-up period. The relationships between postoperative serum ps-Tg level and the clinicopathological characteristics of DTC patients, between recurrence, metastasis of DTC and postoperative serum ps-Tg level were analyzed. Cox regression model was used to analyze the risk factors for postoperative recurrence and metastasis of DTC patients, and receiver operating characteristic (ROC) was used to analyze the predictive value of serum ps-Tg level for postoperative recurrence and metastasis of DTC patients.
      Results  There were no statistically significant differences in serum ps-Tg levels among the patients with different genders, ages and microcalcifications within the mass(P>0.05). There were statistically significant differences in serum ps-Tg levels among the patients with different tumor location, maximum diameter, the number of lesions, relationship between tumor and thyroid capsule, blood flow in and around mass (P < 0.05). Postoperative serum ps-Tg level in the recurrent and metastatic group was significantly higher than that in the non-recurrent and metastatic group (P < 0.05). Cox regression model analysis showed that higher level of postoperative serum ps-Tg, maximum diameter of 1 cm or more, multifocus, mass and owed clear or not clear of thyroid capsule boundary, richful internal and peripheral blood flow were independent risk factors for DTC patients with cervical lymph node metastasis(P < 0.05). ROC curve showed that optimal cutoff value of serum ps-Tg level for prediction of long-term recurrence and metastasis was 13.60 ng/mL, area under curve (AUC) was 0.743, and 95%CI was ranging from 0.555 to 0.995, and corresponding sensitivity and specificity were 0.711, 0.795, respectively.
      Conclusion  Abnormal increase of serum ps-Tg in patients with DTC mostly indicates poor clinicopathological types, which has a certain predictive value for postoperative recurrence and metastasis in patients.

     

/

返回文章
返回